DOI: 10.1002/ame2.12061
The CRIPSR/Cas gene-editing system-an immature but useful toolkit for experimental and clinical medicine
Yuyan Yang
Yue Huang
摘要：A Chinese scientist,Jiankui He,and his creation of the world's first genetically altered baby made headlines recently.As a newly developed gene-editing technique,the CRISPR/Cas system should not be applied to human beings for reproductive purposes until it has been extensively tested.However,numerous experimental research studies in human somatic,germline cells,and even in embryos,have been conducted,which have shown CRISPR/Cas to be a useful tool for human genome editing and a potential therapeutic method for future clinical use.
机标关键词：
论文发表日期：2019-01-01
在线出版日期：2025-08-15（本平台首次上网日期，不代表文献的发表时间）
页数：4( 5-8 )
英文信息